Association of urinary cadmium, circulating fatty acids, and risk of gestational diabetes mellitus: A nested case-control study in China. 2020

Xinping Li, and Yichao Huang, and Yuling Xing, and Chen Hu, and Wenxin Zhang, and Yi Tang, and Weijie Su, and Xia Huo, and Aifen Zhou, and Wei Xia, and Shunqing Xu, and Da Chen, and Yuanyuan Li
Key Laboratory of Environment and Health, Ministry of Education & Ministry of Environmental Protection, and State Key Laboratory of Environmental Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.

Previous studies have observed that cadmium (Cd) exposure of pregnant women was associated with increased risk of gestational diabetes mellitus (GDM). However, the potential mechanism still remains unclear. In addition, various animal studies have suggested that Cd exposure could affect fatty acids (FAs) metabolism, but data on humans are scant. We conducted a nested case-control study to investigate the associations of urinary Cd concentrations with levels of circulating FAs and risk of GDM in pregnant women, and further to examine the role of FAs in mediating the relationship between Cd exposure and risk of GDM. A total of 305 GDM cases were matched to 305 controls on pregnant women's age (±2 years) and infant's gender from a birth cohort study conducted in Wuhan, China. Urinary Cd concentrations and levels of plasma FAs between 10 and 16 gestational weeks were measured using inductively coupled plasma mass spectrometry and gas chromatography-mass spectrometry, respectively. Conditional logistic regressions models were used to estimate the associations of Cd concentrations and levels of FAs with the risk of GDM. Multiple linear regression models were applied to estimate the associations between Cd concentrations and levels of FAs. Mediation analysis was used to assess the mediating role of FAs in the association of Cd with the risk of GDM. Urinary concentrations of Cd in cases (median: 0.69 μg/L) were significantly higher than controls (median: 0.59 μg/L, P < 0.05). Cd concentrations were positively associated with the risk of GDM (Ptrend = 0.003). Compared to the first tertile of Cd, the adjusted odds ratios (95% confidence intervals) of GDM risk were 2.08 (1.29, 3.36) for the second tertile and 2.09 (1.32, 3.33) for the third tertile. Cd concentrations were positively correlated with levels of eicosadienoic acid and arachidonic acid/eicosapentaenoic acid ratio, but negatively correlated with levels of stearic acid, eicosapentaenoic acid, total odd-chain saturated fatty acids, total n-3 polyunsaturated fatty acids (PUFAs), and n-3 PUFAs/n-6 PUFAs ratio. We did not observe evidence that the association of Cd exposure and risk of GDM was mediated through FAs. Our findings confirmed the association of higher Cd exposure with increased risk of GDM in pregnant women, and provided forceful epidemiological evidence for the relation of Cd concentrations and levels of FAs.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002104 Cadmium An element with atomic symbol Cd, atomic number 48, and atomic weight 112.41. It is a metal and ingestion will lead to CADMIUM POISONING.
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China
D005227 Fatty Acids Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed) Aliphatic Acid,Esterified Fatty Acid,Fatty Acid,Fatty Acids, Esterified,Fatty Acids, Saturated,Saturated Fatty Acid,Aliphatic Acids,Acid, Aliphatic,Acid, Esterified Fatty,Acid, Saturated Fatty,Esterified Fatty Acids,Fatty Acid, Esterified,Fatty Acid, Saturated,Saturated Fatty Acids
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D016640 Diabetes, Gestational Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA. Diabetes Mellitus, Gestational,Diabetes, Pregnancy-Induced,Gestational Diabetes,Diabetes, Pregnancy Induced,Gestational Diabetes Mellitus,Pregnancy-Induced Diabetes

Related Publications

Xinping Li, and Yichao Huang, and Yuling Xing, and Chen Hu, and Wenxin Zhang, and Yi Tang, and Weijie Su, and Xia Huo, and Aifen Zhou, and Wei Xia, and Shunqing Xu, and Da Chen, and Yuanyuan Li
January 2023, Frontiers in public health,
Xinping Li, and Yichao Huang, and Yuling Xing, and Chen Hu, and Wenxin Zhang, and Yi Tang, and Weijie Su, and Xia Huo, and Aifen Zhou, and Wei Xia, and Shunqing Xu, and Da Chen, and Yuanyuan Li
January 2022, Frontiers in endocrinology,
Xinping Li, and Yichao Huang, and Yuling Xing, and Chen Hu, and Wenxin Zhang, and Yi Tang, and Weijie Su, and Xia Huo, and Aifen Zhou, and Wei Xia, and Shunqing Xu, and Da Chen, and Yuanyuan Li
January 2021, Journal of diabetes research,
Xinping Li, and Yichao Huang, and Yuling Xing, and Chen Hu, and Wenxin Zhang, and Yi Tang, and Weijie Su, and Xia Huo, and Aifen Zhou, and Wei Xia, and Shunqing Xu, and Da Chen, and Yuanyuan Li
February 2023, Environmental science and pollution research international,
Xinping Li, and Yichao Huang, and Yuling Xing, and Chen Hu, and Wenxin Zhang, and Yi Tang, and Weijie Su, and Xia Huo, and Aifen Zhou, and Wei Xia, and Shunqing Xu, and Da Chen, and Yuanyuan Li
May 2024, The American journal of clinical nutrition,
Xinping Li, and Yichao Huang, and Yuling Xing, and Chen Hu, and Wenxin Zhang, and Yi Tang, and Weijie Su, and Xia Huo, and Aifen Zhou, and Wei Xia, and Shunqing Xu, and Da Chen, and Yuanyuan Li
June 2018, Diabetes research and clinical practice,
Xinping Li, and Yichao Huang, and Yuling Xing, and Chen Hu, and Wenxin Zhang, and Yi Tang, and Weijie Su, and Xia Huo, and Aifen Zhou, and Wei Xia, and Shunqing Xu, and Da Chen, and Yuanyuan Li
March 2009, Cancer causes & control : CCC,
Xinping Li, and Yichao Huang, and Yuling Xing, and Chen Hu, and Wenxin Zhang, and Yi Tang, and Weijie Su, and Xia Huo, and Aifen Zhou, and Wei Xia, and Shunqing Xu, and Da Chen, and Yuanyuan Li
January 2022, Frontiers in nutrition,
Xinping Li, and Yichao Huang, and Yuling Xing, and Chen Hu, and Wenxin Zhang, and Yi Tang, and Weijie Su, and Xia Huo, and Aifen Zhou, and Wei Xia, and Shunqing Xu, and Da Chen, and Yuanyuan Li
October 2019, BMJ open,
Xinping Li, and Yichao Huang, and Yuling Xing, and Chen Hu, and Wenxin Zhang, and Yi Tang, and Weijie Su, and Xia Huo, and Aifen Zhou, and Wei Xia, and Shunqing Xu, and Da Chen, and Yuanyuan Li
January 2022, Frontiers in endocrinology,
Copied contents to your clipboard!